The cause of sleep apnea typically is said to be a
falling back of the tongue. However, according to
scientific literature, this only applies to a small
proportion of patients. In most patients, the soft
palate and upper pharyngeal walls suck togeth. The
causes of these obstructions are physical and can be
anatomical or due to swelling in the nose, as well as
due to impaired nasal function.
The AlaxoLito Nasal Stents can
therefore be used for sleep apnea in two ways:
- the AlaxoLito Plus or Xtreme Nasal Stents to
improve nasal breathing (see
"nasal breathing")
- for CPAP users to prevent nasal alar compression as
well as to counteract the frequent swelling of the
nasal turbinates under artificial ventilation and to
keep the CPAP pressure lower.
The Alaxo Hybrid Stent is a new
development that combines 15 years of experience with
nasal stents in daily use, including from numerous
clinical investigations on sleep apnea patients, as
well as from intensive scientific analyses and
evaluations in an optimized product concept.
Continuous splinting of the
nasal passage and nasopharynx in the region of the soft
palate optimizes the airway in all critical regions.
This improves nasal breathing and prevents the symptom
of airway obstruction at the soft palate where the
symptom occurs. The Alaxo Hybrid Stent is an AlaxoLito
Plus nasal stent extended by an additional section that
splints the soft palate.
The Alaxo Hybrid Stent is
inserted into one nasal passage up to the soft palate
and positioned with the ball-shaped part in the nostril
so that application is easy.
An AlaxoLito Plus nasal stent
is inserted into the second nasal passage (see
"nasal breathing").